Study links common drugs to a lower level of prostate-specific antigen

08/8/2010 | HealthDay News

Commonly used drugs such as painkillers and statins might cause errors in diagnostic tests for prostate cancer because they appear to reduce the level of prostate-specific antigen, researchers reported. "If future studies show that the difference in [prostate-specific antigen] has no bearing on the development of prostate cancer, then it may be necessary to lower the [prostate-specific antigen] threshold for recommending prostate needle biopsies in men who are taking [nonsteroidal anti-inflammatory drugs], statins and thiazide diuretics," the study's lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations